Sernova Corp develops regenerative medicine therapeutic technologies using a medical device and immune protected therapeutic cells to replace proteins or hormones and improve the treatment and quality of life for people with chronic diseases such as insulin-dependent diabetes, hemophilia, and other chronic diseases.

The company believes in building strong collaborations leading to the rapid advancement of Sernova’s products into the market, improving global health and bringing value to patients in concert with our clinical development programs.

Sernova Corp



Event details

Date: June 3 - June 6, 2019

Event contact

Patricia Cosgrove
Senior International Market Consultant
USA: Life Sciences